CD19 and systemic sclerosis: Hu19-CD828Z CAR T-cells generated from SLE, IIM, and SSc patients exhibited comparably robust CD19-targeted cytotoxicity and produced low levels of inflammatory cytokines upon interaction with autologous B-cells.